Boulevard Bio

News

Our round-up of venture capital financings in biotech this week features Vaderis, Aureka, Epicrispr, Infinimmune, and Boulevard Bio.

News

In a handful of strongly-worded warning letters, the FDA is cracking down on sales of unapproved peptides - even if they're labelled for research.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.